The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia

NCT03288038 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

382

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Rosuvastatin
DRUG: Ezetimibe

Sponsor

Shin Poong Pharmaceutical Co. Ltd.